Literature DB >> 20494824

Inactivation of I kappaB-kinase-beta dependent genes in airway epithelium reduces tobacco smoke induced acute airway inflammation.

Sang Yeub Lee1, Marina Miller, Jae Youn Cho, Dae Jin Song, Michael Karin, David H Broide.   

Abstract

We have examined the role of NF-kappaB regulated genes in airway epithelium in mediating tobacco smoke induced airway inflammation in studies of CC10-Cre(tg)/Ikk beta(Delta/Delta) mice in which NF-kappaB signaling through I kappaB-kinase-beta (IKK-beta) is selectively ablated in epithelial cells in the airway. CC10-Cre(tg)/Ikk beta(Delta/Delta) mice exposed to tobacco smoke for seven days had a significant decrease in the number of BAL cells (total cells, neutrophils, and macrophages) as well as significantly reduced numbers of peribronchial cells (F4/80+ and myeloperoxidase+) compared to tobacco exposed WT mice. In addition to the reduction in peribronchial cells, CC10-Cre(tg)/Ikk beta(Delta/Delta) mice exposed to tobacco smoke had a significant decrease in the number of macrophages and neutrophils in the alveolar space suggesting that inactivation of NF-kappaB in the airway epithelium influenced the number of neutrophils and macrophages recruited to the alveolus. Levels of the NF-kappaB regulated chemokines KC and MCP-1 were significantly reduced in lungs of tobacco smoke exposed CC10-Cre(tg)/Ikk beta(Delta/Delta) mice compared to tobacco exposed WT mice. In contrast, there was no significant difference in levels of NF-kappaB regulated MIP-1 alpha between CC10-Cre(tg)/Ikk beta(Delta/Delta) and WT mice. Lung sections of tobacco smoke exposed CC10-Cre(tg)/Ikk beta(Delta/Delta) mice immunostained with KC or MCP-1 antibodies demonstrated reduced expression of these chemokines in the airway epithelium, but not in alveolar epithelium. Overall, these studies demonstrate an important role for NF-kappaB regulated genes in airway epithelium in contributing to acute tobacco smoke induced airway inflammation not only in the peribronchial space but also in the alveolar space. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494824      PMCID: PMC2908188          DOI: 10.1016/j.intimp.2010.05.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  25 in total

Review 1.  Neutrophil infiltration and chemokines.

Authors:  Yoshiro Kobayashi
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

Review 2.  Getting to the site of inflammation: the leukocyte adhesion cascade updated.

Authors:  Klaus Ley; Carlo Laudanna; Myron I Cybulsky; Sussan Nourshargh
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

Review 3.  The cytokine network in chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-28       Impact factor: 6.914

4.  Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice.

Authors:  Dae Hyun Lim; Jae Youn Cho; Marina Miller; Kirsti McElwain; Shauna McElwain; David H Broide
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08       Impact factor: 5.464

5.  NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness.

Authors:  Matthew E Poynter; Roy Cloots; Tiest van Woerkom; Kelly J Butnor; Pamela Vacek; Douglas J Taatjes; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

6.  Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells.

Authors:  Elisabetta Pace; Maria Ferraro; Liboria Siena; Mario Melis; Angela M Montalbano; Malcolm Johnson; Maria R Bonsignore; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2008-01-22       Impact factor: 7.397

7.  Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease.

Authors:  Marina Miller; Jae Youn Cho; Alexa Pham; Joe Ramsdell; David H Broide
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis.

Authors:  Terez Shea-Donohue; Karen Thomas; M Joshua Cody; Louis J Detolla; Karen M Kopydlowski; Masayuki Fukata; Sergio A Lira; Stefanie N Vogel
Journal:  Innate Immun       Date:  2008-04       Impact factor: 2.680

9.  An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation.

Authors:  Carol Ho Yan Fong; Magali Bebien; Arnaud Didierlaurent; Ruth Nebauer; Tracy Hussell; David Broide; Michael Karin; Toby Lawrence
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

10.  The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.

Authors:  J A Gonzalo; C M Lloyd; D Wen; J P Albar; T N Wells; A Proudfoot; C Martinez-A; M Dorf; T Bjerke; A J Coyle; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  3 in total

Review 1.  Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review.

Authors:  Agnieszka Strzelak; Aleksandra Ratajczak; Aleksander Adamiec; Wojciech Feleszko
Journal:  Int J Environ Res Public Health       Date:  2018-05-21       Impact factor: 3.390

2.  Cigarette smoke induced airway inflammation is independent of NF-κB signalling.

Authors:  Joseph M D Rastrick; Christopher S Stevenson; Suffwan Eltom; Megan Grace; Meirion Davies; Iain Kilty; Steven M Evans; Manolis Pasparakis; Matthew C Catley; Toby Lawrence; Ian M Adcock; Maria G Belvisi; Mark A Birrell
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

3.  Medicinal Foods, YT and RH Combination, Suppress Cigarette Smoke-Induced Inflammation and Oxidative Stress by Inhibiting NF-κB/ERK Signaling Pathways.

Authors:  Yuanyuan Li; Lan Wang; Jieping Luo; Yuqin Chen; Wenju Lu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.